170 related articles for article (PubMed ID: 20471435)
1. Regulation of tumor suppressor PDCD4 by novel protein kinase C isoforms.
Nakashima M; Hamajima H; Xia J; Iwane S; Kwaguchi Y; Eguchi Y; Mizuta T; Fujimoto K; Ozaki I; Matsuhashi S
Biochim Biophys Acta; 2010 Sep; 1803(9):1020-7. PubMed ID: 20471435
[TBL] [Abstract][Full Text] [Related]
2. Control of a tumor suppressor PDCD4: Degradation mechanisms of the protein in hepatocellular carcinoma cells.
Matsuhashi S; Hamajima H; Xia J; Zhang H; Mizuta T; Anzai K; Ozaki I
Cell Signal; 2014 Mar; 26(3):603-10. PubMed ID: 24334270
[TBL] [Abstract][Full Text] [Related]
3. Programmed cell death-4 tumor suppressor protein contributes to retinoic acid-induced terminal granulocytic differentiation of human myeloid leukemia cells.
Ozpolat B; Akar U; Steiner M; Zorrilla-Calancha I; Tirado-Gomez M; Colburn N; Danilenko M; Kornblau S; Berestein GL
Mol Cancer Res; 2007 Jan; 5(1):95-108. PubMed ID: 17259349
[TBL] [Abstract][Full Text] [Related]
4. Polymeric black tea polyphenols modulate the localization and activity of 12-O-tetradecanoylphorbol-13-acetate-mediated kinases in mouse skin: mechanisms of their anti-tumor-promoting action.
Kumar G; Dange P; Kailaje V; Vaidya MM; Ramchandani AG; Maru GB
Free Radic Biol Med; 2012 Sep; 53(6):1358-70. PubMed ID: 22841871
[TBL] [Abstract][Full Text] [Related]
5. The role of PKC isoforms in the inhibition of NF-κB activation by vitamin K2 in human hepatocellular carcinoma cells.
Xia J; Matsuhashi S; Hamajima H; Iwane S; Takahashi H; Eguchi Y; Mizuta T; Fujimoto K; Kuroda S; Ozaki I
J Nutr Biochem; 2012 Dec; 23(12):1668-75. PubMed ID: 22475810
[TBL] [Abstract][Full Text] [Related]
6. Inflammation-induced loss of Pdcd4 is mediated by phosphorylation-dependent degradation.
Schmid T; Bajer MM; Blees JS; Eifler LK; Milke L; Rübsamen D; Schulz K; Weigert A; Baker AR; Colburn NH; Brüne B
Carcinogenesis; 2011 Oct; 32(10):1427-33. PubMed ID: 21771721
[TBL] [Abstract][Full Text] [Related]
7. Heregulin-induced apoptosis is mediated by down-regulation of Bcl-2 and activation of caspase-7 and is potentiated by impairment of protein kinase C alpha activity.
Le XF; Marcelli M; McWatters A; Nan B; Mills GB; O'Brian CA; Bast RC
Oncogene; 2001 Dec; 20(57):8258-69. PubMed ID: 11781840
[TBL] [Abstract][Full Text] [Related]
8. Involvement of programmed cell death 4 in transforming growth factor-beta1-induced apoptosis in human hepatocellular carcinoma.
Zhang H; Ozaki I; Mizuta T; Hamajima H; Yasutake T; Eguchi Y; Ideguchi H; Yamamoto K; Matsuhashi S
Oncogene; 2006 Oct; 25(45):6101-12. PubMed ID: 16682950
[TBL] [Abstract][Full Text] [Related]
9. Translation inhibitor Pdcd4 is targeted for degradation during tumor promotion.
Schmid T; Jansen AP; Baker AR; Hegamyer G; Hagan JP; Colburn NH
Cancer Res; 2008 Mar; 68(5):1254-60. PubMed ID: 18296647
[TBL] [Abstract][Full Text] [Related]
10. Activated Ki-Ras suppresses 12-O-tetradecanoylphorbol-13-acetate-induced activation of the c-Jun NH2-terminal kinase pathway in human colon cancer cells.
Okumura K; Shirasawa S; Nishioka M; Sasazuki T
Cancer Res; 1999 May; 59(10):2445-50. PubMed ID: 10344756
[TBL] [Abstract][Full Text] [Related]
11. Exposure of normal human melanocytes to a tumor promoting phorbol ester reverses growth suppression by transforming growth factor beta.
Stavroulaki M; Kardassis D; Chatzaki E; Sakellaris G; Lindschau C; Haller H; Tosca A; Krasagakis K
J Cell Physiol; 2008 Feb; 214(2):363-70. PubMed ID: 17654516
[TBL] [Abstract][Full Text] [Related]
12. Recovery of gap junctional intercellular communication after phorbol ester treatment requires proteasomal degradation of protein kinase C.
Leithe E; Cruciani V; Sanner T; Mikalsen SO; Rivedal E
Carcinogenesis; 2003 Jul; 24(7):1239-45. PubMed ID: 12807762
[TBL] [Abstract][Full Text] [Related]
13. Evidence for involvement of protein kinase C (PKC)-zeta and noninvolvement of diacylglycerol-sensitive PKCs in insulin-stimulated glucose transport in L6 myotubes.
Bandyopadhyay G; Standaert ML; Galloway L; Moscat J; Farese RV
Endocrinology; 1997 Nov; 138(11):4721-31. PubMed ID: 9348199
[TBL] [Abstract][Full Text] [Related]
14. Transforming growth factor-beta3 increases the invasiveness of endometrial carcinoma cells through phosphatidylinositol 3-kinase-dependent up-regulation of X-linked inhibitor of apoptosis and protein kinase c-dependent induction of matrix metalloproteinase-9.
Van Themsche C; Mathieu I; Parent S; Asselin E
J Biol Chem; 2007 Feb; 282(7):4794-4802. PubMed ID: 17150964
[TBL] [Abstract][Full Text] [Related]
15. Knockdown of Pdcd4 results in induction of proprotein convertase 1/3 and potent secretion of chromogranin A and secretogranin II in a neuroendocrine cell line.
Lankat-Buttgereit B; Müller S; Schmidt H; Parhofer KG; Gress TM; Göke R
Biol Cell; 2008 Dec; 100(12):703-15. PubMed ID: 18549351
[TBL] [Abstract][Full Text] [Related]
16. mTOR-dependent transcriptional repression of Pdcd4 tumor suppressor in lung cancer cells.
Vikhreva PN; Shepelev MV; Korobko IV
Biochim Biophys Acta; 2014 Jan; 1839(1):43-9. PubMed ID: 24334141
[TBL] [Abstract][Full Text] [Related]
17. Programmed cell death 4 (PDCD4) mediates the sensitivity of gastric cancer cells to TRAIL-induced apoptosis by down-regulation of FLIP expression.
Wang W; Zhao J; Wang H; Sun Y; Peng Z; Zhou G; Fan L; Wang X; Yang S; Wang R; Fang D
Exp Cell Res; 2010 Sep; 316(15):2456-64. PubMed ID: 20595005
[TBL] [Abstract][Full Text] [Related]
18. Akt phosphorylates and regulates Pdcd4 tumor suppressor protein.
Palamarchuk A; Efanov A; Maximov V; Aqeilan RI; Croce CM; Pekarsky Y
Cancer Res; 2005 Dec; 65(24):11282-6. PubMed ID: 16357133
[TBL] [Abstract][Full Text] [Related]
19. Differential role of PKC isoforms in GnRH and phorbol 12-myristate 13-acetate activation of extracellular signal-regulated kinase and Jun N-terminal kinase.
Dobkin-Bekman M; Rahamin-Ben Navi L; Shterntal B; Sviridonov L; Przedecki F; Naidich-Exler M; Brodie C; Seger R; Naor Z
Endocrinology; 2010 Oct; 151(10):4894-907. PubMed ID: 20810567
[TBL] [Abstract][Full Text] [Related]
20. TGF-β1 targets Smad, p38 MAPK, and PI3K/Akt signaling pathways to induce PFKFB3 gene expression and glycolysis in glioblastoma cells.
Rodríguez-García A; Samsó P; Fontova P; Simon-Molas H; Manzano A; Castaño E; Rosa JL; Martinez-Outshoorn U; Ventura F; Navarro-Sabaté À; Bartrons R
FEBS J; 2017 Oct; 284(20):3437-3454. PubMed ID: 28834297
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]